JP2023524981A5 - - Google Patents
Info
- Publication number
- JP2023524981A5 JP2023524981A5 JP2022567283A JP2022567283A JP2023524981A5 JP 2023524981 A5 JP2023524981 A5 JP 2023524981A5 JP 2022567283 A JP2022567283 A JP 2022567283A JP 2022567283 A JP2022567283 A JP 2022567283A JP 2023524981 A5 JP2023524981 A5 JP 2023524981A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- peptide
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063021814P | 2020-05-08 | 2020-05-08 | |
| US63/021,814 | 2020-05-08 | ||
| PCT/US2021/031260 WO2021226439A2 (en) | 2020-05-08 | 2021-05-07 | Engineered relaxins and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524981A JP2023524981A (ja) | 2023-06-14 |
| JP2023524981A5 true JP2023524981A5 (https=) | 2025-11-18 |
Family
ID=78468429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567283A Pending JP2023524981A (ja) | 2020-05-08 | 2021-05-07 | 操作されたリラキシンおよびその使用の方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230174610A1 (https=) |
| EP (1) | EP4146681A4 (https=) |
| JP (1) | JP2023524981A (https=) |
| KR (1) | KR20230008791A (https=) |
| CN (1) | CN115768801A (https=) |
| AU (1) | AU2021268355A1 (https=) |
| CA (1) | CA3180662A1 (https=) |
| IL (1) | IL297951A (https=) |
| MX (1) | MX2022013770A (https=) |
| WO (1) | WO2021226439A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118510536A (zh) | 2021-11-11 | 2024-08-16 | 泰克托尼治疗股份有限公司 | 松弛素-2融合蛋白类似物及其使用方法 |
| AU2022410335A1 (en) * | 2021-12-15 | 2024-07-18 | Medimmune Limited | Treatment using heterodimeric relaxin fusions |
| AU2024270919A1 (en) * | 2023-05-18 | 2026-01-15 | Tectonic Operating Company, Inc. | Relaxin-2 fusion protein analogs and methods of using same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4835251A (en) * | 1986-06-23 | 1989-05-30 | Genetech, Inc. | Method of chain combination |
| US20110243943A1 (en) * | 2010-04-02 | 2011-10-06 | Athena Discovery, Inc. | Treatment using relaxin-fusion proteins with extended in vivo half-lives |
| US9567386B2 (en) * | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
| RU2014103288A (ru) * | 2011-07-01 | 2015-08-10 | Байер Интеллектчуал Проперти Гмбх | Слитые полипептиды релаксина и их применение |
| JP6822839B2 (ja) * | 2013-09-13 | 2021-01-27 | ザ・スクリップス・リサーチ・インスティテュート | 修飾された治療剤、及びその組成物 |
| IL263079B2 (en) * | 2016-05-18 | 2024-05-01 | Modernatx Inc | Polynucleotides encoding relaxin |
| EP3574004A1 (en) * | 2017-01-25 | 2019-12-04 | Medimmune, LLC | Relaxin fusion polypeptides and uses thereof |
| PE20191716A1 (es) * | 2017-02-08 | 2019-12-05 | Bristol Myers Squibb Co | Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos |
-
2021
- 2021-05-07 CN CN202180033724.4A patent/CN115768801A/zh active Pending
- 2021-05-07 WO PCT/US2021/031260 patent/WO2021226439A2/en not_active Ceased
- 2021-05-07 CA CA3180662A patent/CA3180662A1/en active Pending
- 2021-05-07 JP JP2022567283A patent/JP2023524981A/ja active Pending
- 2021-05-07 EP EP21800239.2A patent/EP4146681A4/en active Pending
- 2021-05-07 IL IL297951A patent/IL297951A/en unknown
- 2021-05-07 US US17/998,057 patent/US20230174610A1/en active Pending
- 2021-05-07 KR KR1020227042680A patent/KR20230008791A/ko active Pending
- 2021-05-07 AU AU2021268355A patent/AU2021268355A1/en active Pending
- 2021-05-07 MX MX2022013770A patent/MX2022013770A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524981A5 (https=) | ||
| JP6265564B2 (ja) | 延長組換えポリペプチドおよび延長組換えポリペプチドを含む組成物 | |
| CN102481331B (zh) | 葡萄糖调节多肽及其制备和使用方法 | |
| CA2667280C (en) | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage | |
| US11192931B2 (en) | Relaxin fusion polypeptides and uses thereof | |
| JP2023518596A5 (https=) | ||
| CA2691898A1 (en) | Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury | |
| CN102153652A (zh) | 一种融合蛋白的表达方法及用途 | |
| JP2024532503A5 (https=) | ||
| CN101240033B (zh) | 一种促胰岛素分泌肽与人血清白蛋白的融合蛋白及其制备方法 | |
| JP2024543455A5 (https=) | ||
| WO2026082147A1 (zh) | 一种双靶点受体激动剂融合蛋白及其应用 | |
| WO1999063086A2 (en) | Insulin-like growth factor binding protein-3 variants | |
| WO2023280133A1 (zh) | 融合蛋白及其应用 | |
| CN118344462A (zh) | 一种用于肺部给药的索马鲁肽突变体、融合蛋白及相关产品 | |
| CN111234015A (zh) | 用于延长药物半衰期的抗体、其融合蛋白和应用 | |
| JP2009536821A (ja) | 新規血栓溶解分子及びその製造法 | |
| CN103601808B (zh) | 钠肽、制备方法及其在制备基因工程药物中的应用 | |
| CN105085659B (zh) | 一种重组利钠肽及其制备方法 | |
| RU2021136703A (ru) | Новый модифицированный слитый белок fc-фрагмента иммуноглобулина и его применение | |
| CN104447982B (zh) | 一种人松弛素h2前体及其制备方法和应用 | |
| RU2025118082A (ru) | Рекомбинантный гемоглобин | |
| WO2026082073A1 (zh) | 一种嵌合利钠肽或其变体及其应用 | |
| CN116063562A (zh) | 一种长效人重组胰高血糖素样肽-1及其应用 | |
| Veis et al. | Type I procollagen heterotrimer assembly is linked to subtle differences in the structures of the pro-α 1 (I) and pro-α 2 (I)-carboxyl-propeptides |